v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
NET INCOME (LOSS) $ 2,229,792 $ 1,967,610 $ (131,735)
Adjustments for:      
Depreciation and amortization 2,308,520 2,189,547 2,149,066
Expected credit losses 31,732 12,856 9,906
Share of profit of equity-accounted investees (16,897) (2,945) (9,537)
Gain on sales of assets (19,557) (8,856) (14,033)
Tax expense 390,505 743,393 (127,993)
Net finance expense 1,556,277 1,669,764 1,353,405
Share-based compensation 28,851 15,794 6,913
Provisions for legal proceedings 189,362 47,229 106,117
Impairment of goodwill and property, plant and equipment 12,767 28,264 30,250
Net realizable value inventory adjustments 18,160 13,957 (6,100)
DOJ (Department of Justice) and antitrust agreements 182,275 253,731 102,500
Fair value adjustment of biological assets (19,148) (158,600) 85,015
Extemporaneous Litigation 20,716 61,016
Extemporaneous Reversal of Tax Credits 58,654
Provision for avian influenza related costs 17,092
Total Adjustments 6,930,447 6,891,414 3,553,774
Changes in assets and liabilities:      
Trade accounts receivable (347,327) (333,628) 624,752
Inventories (793,653) (377,443) 480,524
Recoverable taxes 54,044 45,351 137,678
Other current and non-current assets (123,592) (7,606) (40,938)
Biological assets (820,628) (520,541) (529,365)
Trade accounts payable and supply chain finance 612,566 344,542 (787,017)
Taxes paid in installments (55,715) (60,993) (48,091)
Other current and non-current liabilities (198,577) 62,362 249,454
DOJ and Antitrust agreements payment (402,818) (170,573) (90,300)
Income taxes paid (808,962) (348,666) (70,918)
Changes in operating assets and liabilities (2,884,662) (1,367,195) (74,221)
Cash provided by operating activities 4,045,785 5,524,219 3,479,553
Interest paid (1,302,194) (1,486,820) (1,288,172)
Interest received 188,362 192,150 187,393
Net cash flows provided by operating activities 2,931,953 4,229,549 2,378,774
Cash flows from investing activities      
Purchases of property, plant and equipment (2,099,269) (1,480,298) (1,502,137)
Purchases and disposals of intangible assets (7,125) (10,585) (8,983)
Proceeds from sale of property, plant and equipment 73,200 47,216 71,980
Additional/Acquistion investments in equity-accounted investees (185,675)
Acquisitions, net of cash acquired (5,829) (3,529)
Dividends received 7,268 10,672 12,593
Related party transactions (53,932) 21,171 1,039
Others (45,831) 20,625
Cash used in investing activities (2,311,364) (1,417,653) (1,408,412)
Cash flows from financing activities      
Proceeds from loans and financing 10,087,277 2,976,300 9,035,710
Payments of loans and financing (8,752,762) (2,990,311) (7,091,698)
Derivative instruments received (settled) (86,767) (231,969) (12,745)
Margin cash (16,576) 20,099 (26,602)
Dividends paid / Share premium distribution (1,573,855) (759,301) (447,979)
Dividends paid to non-controlling interest (356,158) (4,296) (5,859)
Purchase of Diamond Pork treasury shares (7,614)
Purchase of treasury shares (600,000)
Payments of leasing contracts (432,516) (417,752) (428,745)
Acquisition of non-controlling interests in the subsidiary PPC (1,294)
Others (39,274)
Cash provided by (used in) financing activities (1,771,925) (1,414,844) 1,022,082
Effect of exchange rate changes on cash and cash equivalents 102,799 (352,897) 50,642
Net change in cash and cash equivalents (1,048,536) 1,044,155 2,043,086
Cash and cash equivalents beginning of period 5,613,672 4,569,517 2,526,431
Cash and cash equivalents at the end of period 4,565,136 5,613,672 4,569,517
Non-cash transactions:      
Non-cash additions to right of use assets and lease liabilities 404,119 504,963 483,698
Capitalized interest 35,033 31,695 68,164
Dividends Prescribed and payable 46 5 696
Interim dividends 379,637
Non-Cash additions to PP&E 12,529
Dividend distribution through liquidation of subsidiaries $ (133,136)